BioMed Research International

BioMed Research International / 2020 / Article

Research Article | Open Access

Volume 2020 |Article ID 4807254 | https://doi.org/10.1155/2020/4807254

Guoyue Liu, Mingjiang Qian, Miao Chen, Tao Chen, Song Qin, "miR-21-5p Suppresses Mitophagy to Alleviate Hyperoxia-Induced Acute Lung Injury by Directly Targeting PGAM5", BioMed Research International, vol. 2020, Article ID 4807254, 12 pages, 2020. https://doi.org/10.1155/2020/4807254

miR-21-5p Suppresses Mitophagy to Alleviate Hyperoxia-Induced Acute Lung Injury by Directly Targeting PGAM5

Academic Editor: Ali I. Abdalla
Received17 Jun 2020
Accepted05 Aug 2020
Published20 Nov 2020

Abstract

Hyperoxia-induced acute lung injury (HALI) is a severe side effect of refractory hypoxemia treatment, for which no effective therapeutic strategy is available. Here, we found that the lung miR-21-5p level was significantly decreased in the rats subjected to hyperoxia. Further, we presented evidence that miR-21-5p was a crucial regulator of mitophagy and mitochondrial dysfunction. Moreover, it proved that miR-21-5p regulated hyperoxia-induced mitophagy and mitochondrial dysfunction by directly binding to the target gene PGAM5. In conclusion, for the first time, we found that miR-21-5p could directly suppress mitophagy and mitochondrial damage during HALI formation.

1. Introduction

Hyperoxia-induced acute lung injury (HALI) is a major clinical problem with high morbidity and mortality, which widely exists during the treatment of refractory hypoxemia [1]. It is reported that hyperoxia exposure stimulates the activation of inflammatory cells and thus results in pulmonary alveoli injury, alveolar-capillary leak, and the development of hyaline membranes [2, 3]. Unfortunately, no effective therapeutic strategies are available for HALI treatment. Therefore, it is necessary to understand further the mechanism of HALI to investigate novel pharmacotherapy.

Accumulated evidence found that mitochondrial dysfunction plays a central role in HALI [4, 5]. This dysfunction leads to the downregulation of ATP production, loss of mitochondrial membrane potential (ΔΨm), and reactive oxygen species (ROS) accumulation in endothelial or epithelial cells. Ultimately, it contributes to mitochondria-mediated cell death, such as apoptosis, autophagy, and necrocytosis [6]. At present, much attention has been given to the events that HALI-induced mitochondrial dysfunction could trigger type II alveolar epithelial cell (AEC-II) apoptosis or necrocytosis [79]. However, in the context of HALI, few studies focus on the selective autophagy of mitochondria, termed as mitophagy. These findings result in a renewed interest in mitophagy and its role in HALI.

Nowadays, microRNAs (miRNAs) have been recently proved to be a new mediator of such stimuli, including ROS, mitochondrial dysfunction, and inflammation [10, 11]. It is a kind of small, endogenous, and noncoding RNA molecules with 21-25 nucleotides. They take part in various pathologic processes by directly targeting the essential genes’ 3 untranslated regions (3UTR). In particular, Syed et al. had found that miR-34a was upregulated in the AEC-II cells and developing lungs, which were subjected to hyperoxia exposure. It suppressed the downstream target gene (angiopoietin-1) to induce the HALI and pulmonary arterial hypertension phenotype [3]. Similarly, in Prajapati et al.’s work, miRNAs have been confirmed to regulate neuron apoptosis by targeting transcript encoding subunit of mitochondrial complexes [12]. Thus, miRNAs have been considered a novel candidate for HALI therapy. However, whether miRNAs control mitophagy during HALI formation remains unclear. Of interest is miR-21-5p, which has been identified as a key mediator inducing acute lung injury and fibrosis [13, 14]. Intriguingly, our previous studies have reported that miR-21-5p was dramatically downregulated in the rat subjected to hyperoxic condition and inhibited apoptosis of type II alveolar epithelial cells through the PTEN/Akt pathway [2, 15]. However, whether miR-21-5p regulates mitophagy during HALI remains elusive.

For this purpose, we established a rat model to investigate the potential mechanism of HALI and found miR-21-5p dramatically decreased during this process, which might associate with HALI formation. Then, we investigated the function of miR-21-5p in regulating mitochondrial damage and mitophagy in our hyperoxia-induced model. Our data demonstrated that the miR-21-5p could significantly inhibit mitochondrial damage and mitophagy in AEC-II cells to protect HALI through directly binding to PGAM5 3UTR.

2. Materials and Methods

2.1. Hyperoxia-Induced Acute Lung Injury Model (HALI Model)

Thirty male Sprague-Dawley rats (200-220 g) were obtained from the Model Animal Research Center of Nanjing University. The rats were given free access to standard rodent food and tap water. All animal experiments were approved by the Animal Care and Use Committee of Zunyi Medical University. According to our previous study [16], the rats were randomly divided into three groups. In order to establish the acute lung injury model, rats were exposed to high concentration (≥95%) oxygen at a flow rate of around 5.0 L/min for 24 h or 48 h. The control group was maintained in the normoxic environment.

2.2. Histological Analysis

The rats were anesthetized after different treatments. Rat lungs were isolated and immersed in 4% paraformaldehyde for 24 h at 4°C. Lung tissues were then embedded in paraffin and sliced into five-micrometer sections. After dewaxing and hydration, the sections were immersed in hematoxylin for 5 min and then treated with an eosin solution for 1 min. Then, the sections were dried and mounted with neutral gel. Finally, the sections were observed by light microscopy.

2.3. Measurement of Cytokines/Chemokines in Bronchoalveolar Lavage (BAL)

After different treatments, the rats were euthanized, and the tracheas were isolated immediately. Then, 5 mL phosphate buffer saline was infused and recollected gently through the trachea (BAL fluid). After centrifuging at for 5 min, the supernatants were used to measure the concentration of malondialdehyde (MDA, Solarbio, Beijing, China) and tumor necrosis factor (TNF-α, Abcam, USA) by the commercial kits (Nanjing Jiancheng, China) according to the manufacturer’s instruction, respectively [17].

2.4. Lung Wet/Dry Weight Ratio

When the rats were euthanized, the lung tissues were isolated from the heart, trachea, and main bronchi. Each lung was wiped dry and weighed and then incubated at 70°C until the weight was not changed. The dry weight was recorded. The ratio was calculated to measure lung edema and water content according to the previous studies [15, 18].

2.5. Western Blot Analysis

The lung tissues were isolated from the mice with different treatments. The cells were collected after normoxia or hyperoxia exposure. Total proteins were then extracted using a Total Protein Extraction Kit (Synthgene Biotech, Nanjing, China) following the manufacturer’s protocol. The protein concentration was measured by a BCA Protein Assay Kit (Synthgene Biotech, Nanjing, China) following the manufacturer’s protocol. Equal protein of each group (30 μg per lane) was separated by 10% SDS-PAGE and transferred onto polyvinylidene fluoride membranes. After blocking with 5% nonfat milk solution for 1 h at room temperature, the membranes were incubated with primary antibodies against light chain 3 (LC3) (1 : 1000, Abcam, Shanghai, China), p62 (1 : 1000, Abcam, Shanghai, China), Beclin1 (1 : 1000, Abcam, Shanghai, China), phosphoglycerate mutase family member 5 (PGAM5, 1 : 1000, Abcam, Shanghai, China), TIM23 (1 : 1000, Abcam, Shanghai, China), TOM20 (1 : 1000, Abcam, Shanghai, China), PINK1 (1 : 1000, Abcam, Shanghai, China), Parkin (1 : 1000, Abcam, Shanghai, China), COX IV (1 : 10000, Abcam, Shanghai, China), and GAPDH (1 : 10000, Abcam, Shanghai, China) overnight at 4°C. Then, membranes were incubated with HRP-conjugated secondary antibody (anti-mouse IgG or anti-rabbit IgG, 1 : 5000, Abcam, Shanghai, China) for 2 h at room temperature. The pictures were detected by a HiSignal™ ECL WB Detection Kit (Synthgene Biotech, Nanjing, China) following the manufacturer’s protocol and quantified with ImageJ software.

2.6. Cell Culture

The isolation of AEC-II cells was performed based on previous studies [16, 17, 19]. In brief, rat lungs were obtained and washed by PBS several times to remove the blood and leukocytes. The tissues were then cut into small pieces and digested by 0.25% trypsin for 25 min at 37°C. After filtering and centrifugation at for 5 min, the cell pellets were collected. Cells were then digested by collagenase for 15 min at 37°C followed by several washes. In order to remove the fibroblasts, cell pellets were placed on a Petri flask overnight for differential adherence. The purity and survival rates of the cells were determined to be >90%. For the cell experiments, 500 μM H2O2 was used to simulate the hyperoxic condition [20]. The control group was maintained in the normoxic condition.

2.7. RNA Extraction and Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR)

The lung tissues were isolated from the mice with different treatments. The cells were collected after normoxia or hyperoxia exposure. For the detection of miRNA expression, total RNA was extracted using a Total RNA Extraction Kit (Synthgene Biotech, Nanjing, China) following the manufacturer’s protocol. RNA quantity and purity were measured by a NanoDrop spectrophotometer (Thermo Fisher, Wilmington, DE, USA). The cDNA was synthesized using a Strand cDNA Synthesis kit (Takara Biotech, Dalian, China) following the manufacturer’s protocol. The protocol was showed as follows: 42°C for 60 min, 70°C for 15 min, and chilling at 4°C. qRT-PCR was then performed using TaqMan™ Fast Advanced Master Mix (Thermo Fisher, Wilmington, DE, USA) with the following procedure: 95°C for 5 min, 95°C for 15 s and extension for 1 min at 60°C for 40 cycles, and 60°C for 5 min. U6 and GAPDH were used as an internal control. The data were normalized by the U6 or GAPDH with the 2-ΔΔCT method [21]. The primers are the following: miR-21-5p: forward 5-GTCAATAGCTTATCAGACTGA-3 and reverse 5-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCA-3; U6: forward 5-CTCGCTTCGGCAGCACACG-3 and reverse 5-AACGCTTCACGAATTTGCGT-3; PGAM5: forward 5-GTGCCACTGGATTAGGGCAA-3 and reverse 5-GGGACTTCTCTGACCAGGCT-3; and GAPDH: forward 5-CAGGACCTCACTCATTGCCC-3 and reverse 5-GACGGACACATTGGGGGTAG-3.

2.8. Measurement of Mitochondrial Membrane Potential

The mitochondrial membrane potential (Δψm) was monitored using a J Mitochondrial membrane potential assay kit with JC-1 (Beyotime, Shanghai, China) according to the manufacturer’s instructions. Briefly, after treatment, the AEC-II cells were washed twice with HBSS (Sigma) and incubated in the dark with JC-1 (7.5 μM; 30 minutes at 37°C). Then, the cells were washed with JC-1 wash buffer. Fluorescence images were captured by confocal microscopy [18].

2.9. Detection of Mitophagy

For the mitophagy assay, AEC-II cells were seeded onto glass coverslips and transfected with GFP-LC3 plasmid using the HiTrans™ LipoPlus Reagent (Synthgene Biotech, Nanjing, China). After 48 h, cells were subjected to hyperoxia exposure (500 μM H2O2) with different treatments. Cells were then washed twice with PBS and incubated with 100 nM MitoTracker Red (Molecular Probes, M7512) at 37°C for 15 minutes. The cells were then fixed with 4% paraformaldehyde for 10 min at room temperature, and images were observed by a confocal microscope (Fluoview FV1000, Olympus). The experiments were repeated at least three times independently.

2.10. Cell Transfection

AEC-II cells were seeded on a 6-well plate and transfected with 500 nM miR-21-5p mimic or mimic control (mimic-NC), 0.5 μg PGAM5 overexpression plasmid (PGAM5 OE), or control plasmid using a Lipofectamine™ 3000 reagent (Thermo Fisher Scientific, Inc.) following the manufacturer’s protocol. The miR-21-5p mimic and related control, PGAM5 overexpression plasmid (PGAM5 OE), and control plasmid were purchased from Synthgene (Nanjing, China). After 48 h, the cells were collected for further experiments. For one group, the cells were cotransfected with PGAM5 OE (0.5 μg) and miR-21-5p mimics (100 pmol) using the same reagent.

2.11. Luciferase Reporter Assay

A fragment of PGAM5 3UTR, including the miR-21-5p binding sites, was predicted via TargetScan 7.2 (http://www.targetscan.org/). The luciferase reporter plasmids of pMIR-PGAM5-3UTR-WT and pMIR-PGAM5-3UTR-MUT were purchased from Synthgene (Nanjing, China). 106 AEC-II cells were cotransfected with the plasmids (0.5 μg) and miR-21-5p mimics (100 pmol), as well as the mimic control using HiTrans™ LipoPlus Reagent (Synthgene Biotech, Nanjing, China). The luciferase intensity was measured after 48 h using the Dual-Glo Luciferase Assay System (Promega, Shanghai, China) following the manufacturer’s protocol. The data were normalized by renilla signals. The experiments were repeated at least three times independently.

2.12. Statistical Analysis

All data in this study were shown as the . Student’s -test was performed to determine the significance between two groups, and one-way or two-way ANOVA with Bonferroni post hoc tests for multiple groups. value < 0.05 was considered statistically significant.

3. Results

3.1. Hyperoxia Activated Mitophagy and Induced Mitochondrial Dysfunction during HALI In Vivo

According to our previous study, we successfully established a lung injury model through hyperoxia administration [15]. Rats exposed to high oxygen showed diffuse pathological changes, including alveolar congestion and inflammatory cell infiltration. Moreover, the degree of injury was aggravated in a time-dependent manner (Figure 1(a)). A significant time-dependent increase had shown in the injury characteristics, including the W/D ratio of lung tissues and TNF-α in the BALF. Compared with the control group, the level of MDA had increased to  nmol/mL after hyperoxia exposure for 24 h () and further reached  nmol/mL at 48 h after hyperoxia administration (Figure 1(b)).

To determine the effect of hyperoxia on mitophagy in vivo, we first assessed the changes in mitophagy protein markers using western blot. The result showed that the expression of mitophagy marker PINK1 and Parkin was significantly elevated along with the prolonged hyperoxia exposure. As a critical pathway in mitophagy regulation, our results indicated that the mitophagy occurred during HALI. Besides, hyperoxia exposure significantly regulated the expression of autophagy-related proteins, with an 8-fold increase of the LC3-II/LC3-I ratio and 5-fold upregulation of Beclin1 expression, as well as a significant decline of the p62 level, in the lung tissue of the hyperoxia 48 h group as compared to the control group. In addition, we found that the expression of mitophagy markers like TIM23 and TOM20 was dropped as compared to that in the control group, suggesting that the mitochondrial content was lost under the hyperoxic condition (Figures 1(c) and 1(d)). We then checked the mitochondrial function by a fluorescence assay. AEC-II cells were isolated from lung tissues of normal rats and treated in vitro with H2O2 exposure for 24 h or 48 h. As shown in Figure 2(a), compared with the control group, the red signal of J-aggregate was time-dependently reduced, while the green signal of monomer was inclined in the H2O2-treated groups.

Next, we sought to identify whether there was a link between severe mitochondrial damage and the formation of the autophagosome in AEC-II cells. Cells were transfected with both MitoTracker Red and GFP-LC3, following exposure to H2O2 for 24 h or 48 h. As shown in Figure 2(b), with time increased, the presence of LC3 puncta was raised and showed a significant overlap with mitochondria. All of these data showed that mitochondrial damage has been aggravated under a long-time hyperoxia administration and thus initiated related mitophagy in the AEC-II cells.

4. miR-21-5p Alleviated Mitochondrial Dysfunction and Decreased Mitophagy in AEC-II Cell Model

Our previous study has demonstrated that hyperoxia exposure markedly decreased miR-21-5p expression in AEC-II cells. Here, we also confirmed that the expression of miR-21-5p was time-dependently downregulated in the rats subjected to hyperoxia. The level of miR-21-5p was dropped about 2-folds when the rats were maintained in the hyperoxia condition for 48 h (). Consistently, we investigated that the miR-21-5p level was also decreased along with the prolongation of stimulation time in vitro. The most significant decrease in it was showed in the 48 h treatment group () (Figure 3).

To investigate the role of miR-21-5p in HALI, H2O2-treated AEC-II cells were transfected with miR-21-5p mimic or mimic-NC. As expected, compared with the control group, the mitochondrial membrane potential level was decreased markedly, while miR-21-5p mimic treatment significantly reversed the reduction of the mitochondrial membrane potential level to repair the mitochondrial dysfunction. Then, we used the fluorescence of mitochondria and lysosome to observe the mitophagy. The overlap of mitochondria and lysosome was induced, comparable to the cells exposed to hyperoxic condition alone (Figures 4(a) and 4(b)).

Accordingly, H2O2 administration increased the expression level of PINK1 and Parkin, while downregulating the protein level of TIM23 and TOM20. In addition, the LC3-II/LC3-I ratio was significantly increased under the H2O2 exposure than that in the normoxia+mimic-NC group, which was and , respectively (). Similarly, a 40-fold upregulation of the Beclin1 expression had been observed in the H2O2+mimic-NC group (). Contrarily, compared with the normoxia+mimic-NC group, there was a marked decline in the p62 expression level of the H2O2+mimic-NC group (). However, the anomalous change of these protein markers had been reversed after miR-21-5p mimic administration (Figure 4(c)). These data offered evidence that miR-21-5p played an important role in mitophagy and mitochondrial function during hyperoxia treatment.

5. miR-21-5p Directly Targets PGAM5 in AEC-II Cells

To identify the target of miR-21-5p, the TargetScan database (http://www.targetscan.org) was used to search the potential targets. Among them, PGAM5 was the candidate gene with the highest score. The binding sites between miR-21-5p and PGAM5 are presented in Figure 5(a). In order to determine the mechanism of miR-21-5p, the wild-type or mutant PGAM5 3UTR were designed and constructed in the downstream of a luciferase reporter gene. The luciferase intensity was reduced obviously by a miR-21-5p mimic in the wild-type group rather than the mutant one (), indicating that miR-21-5p specially banded to the 3UTR of PGAM5-WT and regulated the PGAM5 expression negatively (Figure 5(b)).

6. Hyperoxia Activated Mitophagy and Induced Mitochondrial Dysfunction via miR-21-5p/PGAM5 Axis

To further confirm the function of the miR-21-5p/PGAM5 axis, we transferred PGAM5 plasmid into AEC-II cells under normoxic condition and treated them using miR-21-5p mimic. As shown in Figure 5(c), a 16-fold increase and 6-fold upregulation were observed in the cells after miR-21-5p mimic or PGAM5 plasmid transfection, respectively. Besides, the overexpression of PGAM5 could highly decline the mitochondrial membrane potential level and increase the expression level of LC3 in mitochondria. With miR-21-5p treatment, these phenomena had been reversed (Figures 5(d) and 5(e)). Consistently, as shown in Figure 5(f), miR-21-5p treatment notably decreased the protein level of PGAM5 as compared to the control group (). Moreover, the western blot results demonstrated that the overexpression of PGAM5 in the cells might dramatically upregulate the LC3-II/LC-I ratio and the expression level of PINK1 and Parkin (). However, when the cells were transfected with miR-21-5p mimic and PGAM5 plasmid, the protein levels of these markers were decreased, which suggested that the phenomena of mitophagy were abolished. These experiments revealed that miR-21-5p might suppress mitophagy through binding to PGAM5 3UTR.

7. Discussion

Exposure to the high concentrations of oxygen causes a massive increase in reactive oxygen metabolites, leading to severe inflammation and cell apoptosis in the lungs, which limits the application of oxygen [22]. In this study, we first successfully established a rat model of HALI. After incubation with a high level of oxygen, the rats showed significant lung injury in a time-dependent manner. We further found that the expression level of LC3, p62, and Beclin1 was regulated by hyperoxia exposure, indicating that autophagy had been activated during HALI. Previous studies showed that autophagy is an evolutionarily conserved physiological process, which upregulated rapidly under various stress conditions, including oxidative stress and hyperoxia [23, 24].

As a kind of special autophagy, mitophagy acts as a selective scavenger of mitochondria in physiological and pathological conditions. Numerous studies have proved that the PINK1-Parkin pathway might be activated during the process of mitophagy, accompanied by increased LC3 maturation and declined expression of mitophagy markers such as TIM23 and TOM20, which serve as the biomarker for mitophagy identification [25, 26]. Nowadays, emerging evidence shows that mitophagy may subsequently attenuate apoptosis to maintain normal tissue homeostasis [27]. However, in some specific cellular settings, mitophagy may lead to cell death [28, 29]. In this work, after H2O2 treatment, a time-dependent mitochondrial dysfunction had been performed with the loss of the mitochondrial membrane potential level. Consistently, an increasing number of mitochondria surrounded by lysosomes have been detected with 24 h and 48 h treatment, suggesting mitochondrial mass loss and mitochondrial dysfunction occurrence during HALI. Our findings also demonstrated that H2O2 exposure could activate mitophagy as evidenced by the increased LC3-II/LC3-I ratio and activated PINK-Parkin pathway in AEC-II cells.

MicroRNAs (miRNAs) can negatively regulate gene expression at the posttranscriptional level [30]. Many researchers have demonstrated that overexpression of miR-21-5p in some types of cancer cells has been proved to involve in cellular proliferation and apoptosis [31]. For example, previous studies reported that miR-21-5p inhibits apoptosis in a breast cancer mouse model and gemcitabine-induced cells [32, 33]. Interestingly, in this work, we found that miR-21-5p was expressed both in rat lungs and AEC-II cells. The level of it was significantly decreased after long-time hyperoxia treatment. Then, using genetic gain-of-function strategies, we revealed a promising causal role of increased miR-21-5p, protecting against mitochondrial damage and related mitophagy in AEC-II cells.

To further confirm the target of miR-21-5p, the TargetScan database (http://www.targetscan.org) was used. We found that PGAM5 was a possible target of miR-21-5p. As a critical driver of mitochondrial dysfunction, PGAM5 played an essential role in the intrinsic apoptosis and necrosis pathway [34, 35]. In our model, we identified that overexpression of PGAM5 could highly reduce the mitochondrial membrane potential level and promote mitophagy. miR-21-5p negatively regulated expression of PGAM5 through directly banding the 3UTR of PGAM5 mRNA. Our data thus revealed the role of miR-21-5p and PGAM5, which was believed to be necessary for the regulation of mitochondrial function and the related HALI. All these results indicated that miR-21-5p inhibited hyperoxia-induced HALI, through directly suppressing PGAM5 function in AEC-II cells.

In summary, this study identified that mitophagy was involved in the pathological process of hyperoxia-induced acute lung injury. miR-21-5p contributed to protecting HALI by influencing mitophagy through regulation of the PGAM5 gene.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflict of interest.

Authors’ Contributions

Guoyue Liu and Mingjiang Qian contributed equally to this work. Mingjiang Qian is the co-first author.

Acknowledgments

The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81560019) and the science and technology program of Guizhou Province, China (NO. [2017]7115).

References

  1. M. F. Nyp, S. M. Mabry, A. Navarro et al., “Lung epithelial-specific TRIP-1 overexpression maintains epithelial integrity during hyperoxia exposure,” Physiological Reports, vol. 6, no. 5, p. e13585, 2018. View at: Publisher Site | Google Scholar
  2. S. Qin, M. Chen, H. Ji et al., “miR‑21‑5p regulates type II alveolar epithelial cell apoptosis in hyperoxic acute lung injury,” Molecular Medicine Reports, vol. 17, no. 4, pp. 5796–5804, 2018. View at: Publisher Site | Google Scholar
  3. M. Syed, P. Das, A. Pawar et al., “Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs,” Nature Communications, vol. 8, no. 1, p. 1173, 2017. View at: Publisher Site | Google Scholar
  4. V. R. Narala, J. Fukumoto, H. Hernandez-Cuervo et al., “Akap1 genetic deletion increases the severity of hyperoxia-induced acute lung injury in mice,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 314, no. 5, pp. L860–L870, 2018. View at: Publisher Site | Google Scholar
  5. S. S. Patil, H. Hernandez-Cuervo, J. Fukumoto et al., “Alda-1 attenuates hyperoxia-induced mitochondrial dysfunction in lung vascular endothelial cells,” Aging, vol. 11, no. 12, pp. 3909–3918, 2019. View at: Publisher Site | Google Scholar
  6. G. C. Higgins and M. T. Coughlan, “Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?” British Journal of Pharmacology, vol. 171, no. 8, pp. 1917–1942, 2014. View at: Publisher Site | Google Scholar
  7. L. Li, W. Wu, W. Huang, G. Hu, W. Yuan, and W. Li, “NF-κB RNAi decreases the Bax/Bcl-2 ratio and inhibits TNF-α-induced apoptosis in human alveolar epithelial cells,” Inflammation Research, vol. 62, no. 4, pp. 387–397, 2013. View at: Publisher Site | Google Scholar
  8. V. Panduri, S. A. Weitzman, N. Chandel, and D. W. Kamp, “The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 28, no. 2, pp. 241–248, 2003. View at: Publisher Site | Google Scholar
  9. M. Perl, C. S. Chung, U. Perl et al., “Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 591–601, 2007. View at: Publisher Site | Google Scholar
  10. R. Rao, P. Nagarkatti, and M. Nagarkatti, “Role of miRNA in the regulation of inflammatory genes in staphylococcal enterotoxin B-induced acute inflammatory lung injury and mortality,” Toxicological Sciences, vol. 144, no. 2, pp. 284–297, 2015. View at: Publisher Site | Google Scholar
  11. M. Murri and H. El Azzouzi, “MicroRNAs as regulators of mitochondrial dysfunction and obesity,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 315, no. 2, pp. H291–H302, 2018. View at: Publisher Site | Google Scholar
  12. P. Prajapati, L. Sripada, K. Singh, K. Bhatelia, R. Singh, and R. Singh, “TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells,” Biochimica et Biophysica Acta, vol. 1852, no. 3, pp. 451–461, 2015. View at: Publisher Site | Google Scholar
  13. G. Liu, A. Friggeri, Y. Yang et al., “miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis,” Journal of Experimental Medicine, vol. 207, no. 8, pp. 1589–1597, 2010. View at: Publisher Site | Google Scholar
  14. J. W. Li, L. Wei, Z. Han, and Z. Chen, “Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p,” European Journal of Pharmacology, vol. 852, pp. 68–76, 2019. View at: Publisher Site | Google Scholar
  15. S. Qin, H. Wang, G. Liu, H. Mei, and M. Chen, “miR‑21‑5p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN/AKT signaling in rats,” Molecular Medicine Reports, vol. 20, no. 6, pp. 4953–4962, 2019. View at: Publisher Site | Google Scholar
  16. G. Liu, H. Mei, M. Chen et al., “Protective effect of agmatine against hyperoxia-induced acute lung injury via regulating lncRNA gadd7,” Biochemical and Biophysical Research Communications, vol. 516, no. 1, pp. 68–74, 2019. View at: Publisher Site | Google Scholar
  17. M. N. Ballinger, M. W. Newstead, X. Zeng et al., “TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death,” Journal of Immunology, vol. 189, no. 1, pp. 356–364, 2012. View at: Publisher Site | Google Scholar
  18. Q. Zhang, D. Wu, Y. Yang, T. Liu, and H. Liu, “Dexmedetomidine alleviates hyperoxia-induced acute lung injury via inhibiting NLRP3 inflammasome activation,” Cellular Physiology and Biochemistry, vol. 42, no. 5, pp. 1907–1919, 2017. View at: Publisher Site | Google Scholar
  19. J. Lin, J. Tian, L. Wang et al., “Apoptosis and surfactant protein-C expression inhibition induced by lipopolysaccharide in AEC II cell may associate with NF-κB pathway,” The Journal of Toxicological Sciences, vol. 42, no. 1, pp. 53–61, 2017. View at: Publisher Site | Google Scholar
  20. Y. Wang, S. I. Feinstein, and A. B. Fisher, “Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress,” Journal of Cellular Biochemistry, vol. 104, no. 4, pp. 1274–1285, 2008. View at: Publisher Site | Google Scholar
  21. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  22. C. R. Carvalho, G. de Paula Pinto Schettino, B. Maranhao, and E. P. Bethlem, “Hyperoxia and lung disease,” Current Opinion in Pulmonary Medicine, vol. 4, no. 5, pp. 300–304, 1998. View at: Publisher Site | Google Scholar
  23. K. Nakahira, M. A. P. Porras, and A. M. K. Choi, “Autophagy in pulmonary diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 194, no. 10, pp. 1196–1207, 2016. View at: Publisher Site | Google Scholar
  24. S. W. Ryter, K. Nakahira, J. A. Haspel, and A. M. K. Choi, “Autophagy in pulmonary diseases,” Annual Review of Physiology, vol. 74, no. 1, pp. 377–401, 2012. View at: Publisher Site | Google Scholar
  25. Q. Jin, R. Li, N. Hu et al., “DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways,” Redox Biology, vol. 14, pp. 576–587, 2018. View at: Publisher Site | Google Scholar
  26. G. Ashrafi and T. L. Schwarz, “The pathways of mitophagy for quality control and clearance of mitochondria,” Cell Death and Differentiation, vol. 20, no. 1, pp. 31–42, 2013. View at: Publisher Site | Google Scholar
  27. H. Dai, Y. Deng, J. Zhang et al., “PINK1/Parkin-mediated mitophagy alleviates chlorpyrifos-induced apoptosis in SH-SY5Y cells,” Toxicology, vol. 334, pp. 72–80, 2015. View at: Publisher Site | Google Scholar
  28. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death and Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at: Publisher Site | Google Scholar
  29. Q.-p. Liu, D.-x. Zhou, L. Sun et al., “Bone marrow mesenchymal stem cells ameliorates seawater-exposure-induced acute lung injury by inhibiting autophagy in lung tissue,” Pathology Research International, vol. 2014, Article ID 104962, 7 pages, 2014. View at: Publisher Site | Google Scholar
  30. L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews. Genetics, vol. 5, no. 7, pp. 522–531, 2004. View at: Publisher Site | Google Scholar
  31. L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund, “Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells,” The Journal of Biological Chemistry, vol. 283, no. 2, pp. 1026–1033, 2008. View at: Publisher Site | Google Scholar
  32. M. L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y. Y. Mo, “miR-21-mediated tumor growth,” Oncogene, vol. 26, no. 19, pp. 2799–2803, 2007. View at: Publisher Site | Google Scholar
  33. F. Meng, R. Henson, M. Lang et al., “Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines,” Gastroenterology, vol. 130, no. 7, pp. 2113–2129, 2006. View at: Publisher Site | Google Scholar
  34. W. Xu, L. Jing, Q. Wang et al., “Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution,” Oncotarget, vol. 6, no. 30, pp. 30017–30034, 2015. View at: Publisher Site | Google Scholar
  35. Z. Wang, H. Jiang, S. Chen, F. Du, and X. Wang, “The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways,” Cell, vol. 148, no. 1-2, pp. 228–243, 2012. View at: Publisher Site | Google Scholar

Copyright © 2020 Guoyue Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views23
Downloads8
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.